Lipid Testing After Myocardial Infarction at the Montreal Heart Institute (NCT06388668)
Timing of Lipid Testing During Hospitalization for MI and Subsequent Management of Dyslipidemia An Observational Study to Reduce the Care Gaps in Dyslipidemia in Canada
🩺 Plain-English Summary (8th-Grade Level)
Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization. It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute. Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission. Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.
Who can join: Review the eligibility criteria below.
Location: Montreal Heart Institute — Montreal, Quebec
Age range: 18 Years
🧪 Interventions in This Study
- Lipid panel (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Montreal Heart Institute — Montreal, Quebec
- Montreal Heart Institute — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (514) 376-3330
Email: suzy.otis@icm-mhi.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Dyslipidemias
- Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity — Storrs, Connecticut
- Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction — Toronto, Ontario
- Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels — Philadelphia, Pennsylvania
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) — Los Angeles, California
- Group Medical Visits for Patients With Dyslipidemia — Dieppe, New Brunswick
Explore by condition: All Dyslipidemias clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.